Johnson & Johnson (JNJ) has submitted a new application to the U.S. FDA to expand the use of Stelara (ustekinumab) for treating children aged two and older with moderate to severe ulcerative colitis.

For the third straight quarter, AbbVie has jacked up its revenue forecast for 2025. The Illinois drugmaker has raised its guidance by $400 million, now expecting sales to reach $60.9 billion. | ...

PHOENIX -- A first-in-class oral miR-124 enhancer significantly improved clinical remission and endoscopic outcomes for ...

Sugar rationing in the first few years of life -- as happened for young kids in Britain during World War II -- was associated with a lower risk of metabolic dysfunction-associated steatotic liver ...

SEC kicker for Auburn football, and had to battle ulcerative colitis and Crohn's disease to make a heart-warming return.

Lower alpha diversity and distinct beta diversity were seen for patients with impaired vs preserved IBDQ-32 scores.

Learn more about whether Alvotech or Arcus Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

New data reinforce rosnilimab’s efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...

The new approval allows patients to transition to a single 200mg subcutaneous injection once every 4 weeks, following completion of the induction phase.

Lemond Nutrition, a registered dietitian private practice in Plano, Texas, is joining MYOR, a nationwide community of registered dietitian practices committed to improving health outcomes through ...

Learn about the importance of protein for ulcerative colitis, specific protein needs, and the top UC-friendly sources to support healing and minimize flares.